Concepts (98)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Levodopa | 6 | 2015 | 36 | 0.820 |
Why?
|
| Parkinsonian Disorders | 3 | 2014 | 22 | 0.430 |
Why?
|
| Parkinson Disease | 3 | 2015 | 178 | 0.390 |
Why?
|
| Antiparkinson Agents | 2 | 2014 | 16 | 0.370 |
Why?
|
| Aphakia | 2 | 2010 | 8 | 0.350 |
Why?
|
| Dyskinesias | 1 | 2010 | 7 | 0.340 |
Why?
|
| Cholinergic Fibers | 1 | 2010 | 24 | 0.340 |
Why?
|
| Dopamine | 6 | 2010 | 282 | 0.330 |
Why?
|
| Dyskinesia, Drug-Induced | 3 | 2015 | 20 | 0.280 |
Why?
|
| Mice, Neurologic Mutants | 1 | 2007 | 18 | 0.260 |
Why?
|
| Disease Models, Animal | 4 | 2015 | 2550 | 0.230 |
Why?
|
| Gene Expression Regulation | 2 | 2010 | 2059 | 0.220 |
Why?
|
| Neurons | 2 | 2010 | 1653 | 0.210 |
Why?
|
| Corpus Striatum | 3 | 2015 | 92 | 0.190 |
Why?
|
| Dopamine Agents | 3 | 2010 | 32 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-fos | 2 | 2007 | 67 | 0.130 |
Why?
|
| Receptors, Histamine H2 | 1 | 2015 | 5 | 0.110 |
Why?
|
| Cholinergic Neurons | 1 | 2015 | 11 | 0.110 |
Why?
|
| Mice, Transgenic | 4 | 2014 | 1645 | 0.110 |
Why?
|
| Mice | 9 | 2015 | 12538 | 0.110 |
Why?
|
| Neostriatum | 1 | 2014 | 25 | 0.100 |
Why?
|
| Parasympathetic Nervous System | 1 | 2014 | 36 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 5 | 2015 | 3489 | 0.090 |
Why?
|
| Aminoacetonitrile | 1 | 2010 | 3 | 0.090 |
Why?
|
| 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 2 | 2008 | 10 | 0.090 |
Why?
|
| Choline O-Acetyltransferase | 1 | 2010 | 25 | 0.090 |
Why?
|
| Adenosine A2 Receptor Antagonists | 1 | 2010 | 14 | 0.080 |
Why?
|
| Substantia Nigra | 2 | 2007 | 30 | 0.080 |
Why?
|
| Homeodomain Proteins | 2 | 2010 | 563 | 0.080 |
Why?
|
| Movement Disorders | 1 | 2010 | 45 | 0.080 |
Why?
|
| Motor Skills | 1 | 2010 | 80 | 0.080 |
Why?
|
| Animals | 9 | 2015 | 28914 | 0.070 |
Why?
|
| Phosphorylation | 1 | 2010 | 1157 | 0.070 |
Why?
|
| Paraquat | 1 | 2007 | 8 | 0.070 |
Why?
|
| Nerve Degeneration | 1 | 2008 | 84 | 0.070 |
Why?
|
| RGS Proteins | 1 | 2007 | 19 | 0.070 |
Why?
|
| Cytosol | 1 | 2008 | 198 | 0.070 |
Why?
|
| Oxidative Stress | 2 | 2008 | 483 | 0.070 |
Why?
|
| Dynorphins | 1 | 2007 | 14 | 0.070 |
Why?
|
| Enkephalins | 1 | 2007 | 15 | 0.070 |
Why?
|
| Oncogene Proteins | 1 | 2007 | 65 | 0.070 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2007 | 112 | 0.070 |
Why?
|
| Learning | 1 | 2010 | 305 | 0.060 |
Why?
|
| Behavior, Animal | 4 | 2014 | 394 | 0.060 |
Why?
|
| Afferent Pathways | 1 | 2007 | 78 | 0.060 |
Why?
|
| Protein Precursors | 1 | 2007 | 138 | 0.060 |
Why?
|
| Transcription Factors | 2 | 2010 | 1730 | 0.060 |
Why?
|
| Aging | 1 | 2005 | 766 | 0.040 |
Why?
|
| Tyrosine 3-Monooxygenase | 2 | 2007 | 45 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 2014 | 1828 | 0.030 |
Why?
|
| Famotidine | 1 | 2015 | 3 | 0.030 |
Why?
|
| Dicyclomine | 1 | 2015 | 4 | 0.030 |
Why?
|
| Histamine H2 Antagonists | 1 | 2015 | 13 | 0.030 |
Why?
|
| Psychomotor Performance | 2 | 2008 | 505 | 0.030 |
Why?
|
| Time Factors | 3 | 2010 | 5585 | 0.030 |
Why?
|
| Hydroxydopamines | 1 | 2014 | 7 | 0.030 |
Why?
|
| Diphtheria Toxin | 1 | 2014 | 22 | 0.030 |
Why?
|
| Denervation | 1 | 2014 | 25 | 0.030 |
Why?
|
| Interneurons | 1 | 2015 | 106 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2010 | 2161 | 0.030 |
Why?
|
| DNA, Complementary | 1 | 2014 | 394 | 0.020 |
Why?
|
| Adenoviridae | 1 | 2014 | 342 | 0.020 |
Why?
|
| Age Factors | 2 | 2008 | 1963 | 0.020 |
Why?
|
| Action Potentials | 1 | 2015 | 618 | 0.020 |
Why?
|
| Rotarod Performance Test | 1 | 2010 | 9 | 0.020 |
Why?
|
| Benzazepines | 1 | 2010 | 65 | 0.020 |
Why?
|
| Reaction Time | 1 | 2010 | 323 | 0.020 |
Why?
|
| Silver Staining | 1 | 2008 | 6 | 0.020 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2008 | 24 | 0.020 |
Why?
|
| Neurotoxins | 1 | 2008 | 48 | 0.020 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2008 | 37 | 0.020 |
Why?
|
| Protein Deglycase DJ-1 | 1 | 2007 | 6 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2008 | 138 | 0.020 |
Why?
|
| Doxycycline | 1 | 2008 | 37 | 0.020 |
Why?
|
| Peroxiredoxins | 1 | 2007 | 14 | 0.020 |
Why?
|
| Herbicides | 1 | 2007 | 36 | 0.020 |
Why?
|
| Prosencephalon | 1 | 2008 | 68 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2014 | 1323 | 0.020 |
Why?
|
| Ubiquitination | 1 | 2007 | 81 | 0.020 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2007 | 51 | 0.020 |
Why?
|
| Functional Laterality | 1 | 2008 | 208 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2007 | 296 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2007 | 329 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2007 | 873 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2008 | 910 | 0.010 |
Why?
|
| Brain | 2 | 2007 | 2482 | 0.010 |
Why?
|
| Electrochemistry | 1 | 2005 | 60 | 0.010 |
Why?
|
| Gene Targeting | 1 | 2005 | 78 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 2005 | 232 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2005 | 311 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2005 | 444 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2005 | 797 | 0.010 |
Why?
|
| Protein Folding | 1 | 2005 | 295 | 0.010 |
Why?
|
| Genotype | 1 | 2005 | 1882 | 0.010 |
Why?
|
| Proteins | 1 | 2005 | 816 | 0.010 |
Why?
|
| Male | 3 | 2007 | 45870 | 0.010 |
Why?
|
| Mutation | 1 | 2005 | 4374 | 0.010 |
Why?
|
| Female | 1 | 2005 | 50030 | 0.000 |
Why?
|